English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Vancomycin therapy has long been individualized through concentration monitoring. Because the therapeutic drug concentration monitoring (TDM) service is not available in all hospitals, ways to predict its area under the curve (AUC) using estimated creatinine clearance (CLcr) without drug concentration have been sought. More than 80% of vancomycin is eliminated via renal excretion and its clearance (CL) is known to be approximately 50-80% of measured glomerular filtration rate (GFR) [1]. Thus, an equation describing linear relationship between vancomycin clearance (CL) and CLcr may be used to predict vancomycin AUC without measuring its concentration.

Overestimation of Vancomycin Clearance by the Linear Regression Formula in Rodvold's Report: Why?